Bioxytran Inc. Appoints Two Investment Bankers from Westbury Group to Its Advisory Board
September 13, 2019 14:39 ET
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, Sept. 13, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company, focused on delivering a small molecule carrying oxygen to the...
Bioxytran Inc. to Attend Multiple Investor Conferences in September
August 30, 2019 14:31 ET
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, Aug. 30, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of novel anti-necrosis drugs designed to treat...
Bioxytran Inc. Announces Appointment of Dr. Hana Chen-Walden to Scientific Advisory Board
August 08, 2019 07:00 ET
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, Aug. 08, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of anti-necrosis drugs designed to treat...
Bioxytran Inc. Appoints Cynthia Ekberg Tsai to Company Advisory Board
August 01, 2019 07:00 ET
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, Aug. 01, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company with a pipeline of anti-necrosis drugs designed to treat hypoxia by...
Bioxytran Inc. Bolsters Advisory Board with Addition of Veteran Financial Advisor Jonathan Barkman
July 26, 2019 15:52 ET
|
Bioxytran Inc.
BOSTON, July 26, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of anti-necrosis drugs designed to treat hypoxia by...
Avise Analytics Initiates Coverage on Bioxytran Inc.
July 23, 2019 07:00 ET
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, July 23, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of anti-necrosis drugs designed to treat...
Bioxytran Inc. Invited to New York Venture Summit
July 09, 2019 13:54 ET
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, July 09, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of novel anti-necrosis drugs designed to...
Bioxytran, Inc. Announces Public Company Executive Steve Aust to Join Advisory Board
June 12, 2019 07:00 ET
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, June 12, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of novel anti-necrosis drugs designed to...
BIOXYTRAN’S MDX VIEWER DEMONSTRATES EARLY WARNING SIGNS OF BRAIN HEALTH DURING CARDIOVASCULAR SURGERIES
June 06, 2019 07:00 ET
|
Bioxytran Inc.
MDX Viewer use during open heart surgery is an essential vital sign that could mitigate the risk of brain damage caused by prolonged oxygen deprivation during perioperative cardiovascular procedures...
Bioxytran Inc. Announces Availability of Updated Investor Presentation
May 29, 2019 10:22 ET
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, May 29, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company with a pipeline of anti-necrosis drugs designed to treat hypoxia by...